Neoadjuvant GMCI Plus mFOLFIRINOX and Chemoradiation for Non-Metastatic Pancreatic Adenocarcinoma

Update Il y a 5 ans
Reference: NCT02446093

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The study will investigate if the addition of GMCI to neoadjuvant mFOLFIRINOX + chemoradiation is safe and improves the clinical outcome of borderline resectable and unresectable locally advanced pancreatic adenocarcinoma, as measured by resection rate, progression-free survival and overall survival.


Inclusion criteria

  • PANCREATIC ADENOCARCINOMA'

Links